Cancer Letters
Volume 286, Issue 2 , Pages 223-231 , 28 December 2009

Waltonitone induces human hepatocellular carcinoma cells apoptosis in vitro and in vivo

  • Zhang Zhang

      Affiliations

    • Key Laboratory of Standardization of Chinese Medicines of Ministry of Education, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Cai Lun Road 1200, Shanghai 201203, China
    • Glycobiology and Glycochemistry Laboratory, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zu Chong Zhi Road 555, Shanghai 201203, China
    • ,
  • Shuo Wang

      Affiliations

    • Glycobiology and Glycochemistry Laboratory, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zu Chong Zhi Road 555, Shanghai 201203, China
    • ,
  • Hong Qiu

      Affiliations

    • Glycobiology and Glycochemistry Laboratory, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zu Chong Zhi Road 555, Shanghai 201203, China
    • ,
  • Chaohui Duan

      Affiliations

    • Key Laboratory of Standardization of Chinese Medicines of Ministry of Education, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Cai Lun Road 1200, Shanghai 201203, China
    • ,
  • Kan Ding

      Affiliations

    • Glycobiology and Glycochemistry Laboratory, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zu Chong Zhi Road 555, Shanghai 201203, China
    • Corresponding Author InformationCorresponding authors. Tel./fax: +86 21 50806928 (K. Ding), tel.: +86 21 51322507; fax: +86 21 51322519 (Z.-T. Wang).
    • ,
  • Zhengtao Wang

      Affiliations

    • Key Laboratory of Standardization of Chinese Medicines of Ministry of Education, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Cai Lun Road 1200, Shanghai 201203, China
    • Corresponding Author InformationCorresponding authors. Tel./fax: +86 21 50806928 (K. Ding), tel.: +86 21 51322507; fax: +86 21 51322519 (Z.-T. Wang).

Received 27 March 2009 ,Revised 25 May 2009 ,Accepted 26 May 2009.

References 

  1. Motola-Kuba D, Zamora-Valdes D, Uribe M, Mendez-Sanchez N. Hepatocellular carcinoma: an overview. Ann. Hepatol. 2006;5:16–24
  2. Colombo M. Natural history of hepatocellular carcinoma. Ann. Ital. Chir. 2008;79:91–97
  3. Gish RG, Baron A. Hepatocellular carcinoma (HCC): current and evolving therapies. IDrugs. 2008;11:198–203
  4. Ye SL. Current aspects on standard therapy for primary hepatocellular carcinoma. Chinese J. Hepatol. 2008;16:1–2
  5. Poupon R, Fartoux L, Rosmorduc O. Therapeutic advances in hepatocellular carcinoma. Bull. Acad. Natl. Med. 2008;192:23–32
  6. Normile D. Asian medicine: the new face of traditional Chinese medicine. Science. 2003;299:188–190
  7. Jiang WY. Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. Trends. Pharmacol. Sci. 2005;26:558–563
  8. Yuan R, Lin Y. Traditional Chinese medicine: an approach to scientific proof and clinical validation. Pharmacol. Ther. 2000;86:191–198
  9. Chen YY, Liang JY. Research progress on Gentiana L. Strait. Pharm. J. 2008;20:1–4
  10. Jiang WX, Xue BY. Hepatoprotective effects of Gentiana scabra on the acute liver injuries in mice. China J. Chinese Materia. Medica. 2005;30:1105–1107
  11. Duan CH, Shi BJ, Wu LH, Chou GX, Wang ZT. Chemical constituents of Gentiana waltonii. China J. Nat. Med. 2007;5:417–420
  12. Ovesna Z, Vachalkova A, Horvathova K, Tothova D. Pentacyclic triterpenoic acids: new chemoprotective compound. Neoplasma. 2004;51:327–333
  13. Safayhi H, Sailer ER. Anti-inflammatory actions of pentacyclic triterpenes. Planta Med. 1997;63:487–493
  14. Alakurtti S, Makela T, Koskimies S, Yli-Kauhaluoma J. Pharmacological properties of the ubiquitous natural product betulin. Eur. J. Pharm. Sci. 2006;29:1–13
  15. Ikeda Y, Murakami A, Ohigashi H. Ursolic acid: an anti- and pro-inflammatory triterpenoid. Mol. Nutr. Food Res. 2008;52:26–42
  16. Huang L, Chen CH. Molecular targets of anti-HIV-1 triterpenes. Curr. Drug Targets Infect. Disord. 2002;2:33–36
  17. Liu J. Oleanolic acid and ursolic acid: research perspectives. J. Ethnopharmacol. 2005;100:92–94
  18. Ikeda Y, Murakami A, Ohigashi H. Ursolic acid promotes the release of macrophage migration inhibitory factor via ERK2 activation in resting mouse macrophages. Biochem. Pharmacol. 2005;70:1497–1505
  19. Harmand PO, Duval R, Delage C, Simon A. Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and caspase-3 activation in M4Beu melanoma cells. Int. J. Cancer. 2005;114:1–11
  20. You HJ, Choi CY, Kim JY, Park SJ, Hahm KS, Jeong HG. Ursolic acid enhances nitric oxide and tumor necrosis factor-alpha production via nuclear factor-kappaB activation in the resting macrophages. FEBS Lett. 2001;509:156–160
  21. Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, Roskams T, et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology. 2004;40:667–676
  22. Walzer N, Kulik LM. Hepatocellular carcinoma: latest developments. Curr. Opin. Gastroenterol. 2008;24:312–319
  23. Meier P, Finch A, Evan G. Apoptosis in development. Nature. 2000;407:796–801
  24. Kountouras J, Zavos C, Chatzopoulos D. Apoptosis in hepatocellular carcinoma. Hepatogastroenterology. 2003;50:242–249
  25. Ghavami S, Hashemi M, Kadkhoda K, Alavian SM, Bay GH, Los M. Apoptosis in liver diseases-detection and therapeutic applications. Med. Sci. Monit. 2005;11:RA337–345
  26. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 1972;26:239–257
  27. Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407:770–776
  28. Eichhorst ST. Modulation of apoptosis as a target for liver disease. Expert Opin. Ther. Tar. 2005;9:83–99
  29. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science. 1997;278:294–298
  30. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995;376:37–43
  31. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Ann. Rev. Cell Dev. Biol. 1999;15:269–290
  32. Leist M, Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 2001;2:589–598
  33. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1309–1312
  34. Susin SA, Zamzami N, Kroemer G. Mitochondria as regulators of apoptosis: doubt no more. Biochim. Biophys. Acta. 1998;1366:151–165
  35. Petit PX, Zamzami N, L J, Vayssiere , Mignotte B, Kroemer G, et al. Implication of mitochondria in apoptosis. Mol. Cell Biochem. 1997;174:185–188
  36. Nagata S. Apoptosis by death factor. Cell. 1997;88:355–365
  37. Yoon JH, Gores GJ. Death receptor-mediated apoptosis and the liver. J. Hepatol. 2002;37:400–410
  38. Schmitz I, Kirchhoff S, Krammer PH. Regulation of death receptor-mediated apoptosis pathways. Int. J. Biochem. Cell Biol. 2000;32:1123–1136
  39. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008;9:47–59

PII: S0304-3835(09)00378-4

doi: 10.1016/j.canlet.2009.05.023

Cancer Letters
Volume 286, Issue 2 , Pages 223-231 , 28 December 2009

Article Tools

* Image Usage & Resolution